SBRA - Sabra Health Care R... Stock Analysis | Stock Taper
Logo
Sabra Health Care REIT, Inc.

SBRA

Sabra Health Care REIT, Inc. NASDAQ
$19.89 -1.92% (-0.39)

Market Cap $5.02 B
52w High $21.28
52w Low $17.13
Dividend Yield 6.46%
Frequency Quarterly
P/E 31.57
Volume 3.23M
Outstanding Shares 252.19M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q1-2026 $221.75M $96.63M $40.88M 18.43% $0.16 $92.61M
Q4-2025 $211.9M $66.91M $27.23M 12.85% $0.11 $107.98M
Q3-2025 $190.04M $60.83M $22.54M 11.86% $0.09 $100.36M
Q2-2025 $189.15M $56.1M $65.54M 34.65% $0.28 $137.17M
Q1-2025 $183.54M $56.22M $40.3M 21.96% $0.17 $111.31M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q1-2026 $123.45M $5.59B $2.8B $2.79B
Q4-2025 $71.54M $5.49B $2.67B $2.82B
Q3-2025 $200.6M $5.56B $2.74B $2.82B
Q2-2025 $95.17M $5.33B $2.62B $2.71B
Q1-2025 $22.65M $5.23B $2.53B $2.7B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2026 $40.81M $98.36M $-105.09M $52.1M $45.31M $98.36M
Q4-2025 $27.23M $87.43M $-116.55M $-100.89M $-129.38M $87.43M
Q3-2025 $22.52M $99.96M $-199.84M $206.17M $105.87M $99.96M
Q2-2025 $65.54M $80.96M $-45.13M $36.73M $72.75M $80.96M
Q1-2025 $40.3M $80.26M $-16.44M $-101.24M $-37.44M $80.26M

Revenue by Products

Product Q2-2025Q3-2025Q4-2025Q1-2026
Health Care Resident Service Ancillary Service
Health Care Resident Service Ancillary Service
$0 $0 $0 $0

Q1 2026 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Sabra Health Care REIT, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Sabra shows a clear financial and operational turnaround, with rising revenue, much-improved profitability, and strong, steady cash flow that comfortably supports dividends. Its portfolio is diversified across essential healthcare and senior living segments that benefit from long-term demographic demand. Management brings deep operator experience, which underpins strong tenant relationships and a more hands-on SHOP strategy, while practical innovation in technology and sustainability enhances property performance and competitive positioning.

! Risks

Key concerns center on the balance sheet and operating leverage: liquidity ratios have weakened sharply as short-term debt and other current liabilities have surged, raising refinancing and near-term funding risk. Retained earnings have historically been negative and were reset through capital actions rather than built steadily through profits. Overhead costs are rising faster than revenue, and capital expenditures are very low, potentially limiting organic growth in the asset base. The business also faces external risks from healthcare regulation, reimbursement changes, labor pressures, and interest rate movements.

Outlook

The overall picture points to a company with improving earnings power and strong cash generation, operating in a sector with favorable long-term demand drivers but meaningful structural and financial risks. Future performance will likely hinge on how well Sabra manages its debt structure and liquidity, executes on expanding and optimizing its SHOP and behavioral health platforms, and continues to validate the returns from its technology and sustainability initiatives. If these elements are balanced carefully, Sabra could sustain its recent momentum, but its reliance on capital markets and the complexity of the healthcare ecosystem remain important constraints and watchpoints.